Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?
Bei-Ning WANG1
Yu-Xi LI2
Wei MA2
Song-Yun CHU2
Zhi-Hao LIU2
Wen-Hui DING2
Jian-Ping LI3
1.Department of Nephrology, Peking University First Hospital, Beijing, China2.Department of Cardiology, Peking University First Hospital, Beijing, China3.Key Laboratory of Molecular Cardiovascular Sciences of Ministry ofEducation, Health Science Center, Peking University, Beijing, China
摘要：The diagnosis of pulmonary hypertension (PH) should be made by combining clinical manifestations and echocardio-graphic probability.[1] Following the confirmation of PH, the classification should begin with the more common groups[group 2 (PH due to left heart disease) and group 3 (PH due to lung diseases and/or hypoxia)],then group 4 (chronic thromboembolic PH and other pulmonary artery obstruc?tions) and finally group 1 (pulmonary arterial hypertension)and group 5 (PH with unclear and/or multifactorial mecha?nisms).[1] In this case,we demonstrate a rare scenario of obstruction-caused group 4 PH.
机标关键词：
论文发表日期：2020-11-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：5( 723-727 )
英文信息